PAHC vs. SYK: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Jun 22, 2026

What Makes Phibro (PAHC) a New Buy Stock

Phibro (PAHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research • Jun 17, 2026

Should You Continue to Hold PAHC Stock in Your Portfolio?

Phibro Animal Health gains from Animal Health strength and Zoetis MFA integration, but macro and FX headwinds remain as the stock rises 27.6% over the past year.

Zacks Investment Research • Jun 15, 2026

Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?

Corcoran purchased 10,000 shares for a transaction value of approximately ~$318,000 on May 29, 2026. The buy increased his direct ownership by 31.79%, bringing his post-transaction direct holdings to 41,459 shares.

The Motley Fool • Jun 13, 2026

PAHC Stock: What's Driving Phibro's Animal Health Growth

Phibro Animal Health unit drove 74% of fiscal 2025 revenue, fueled by MFA, vaccines and global expansion, helping offset pressure in other businesses.

Zacks Investment Research • Jun 12, 2026

Is PAHC Undervalued at 10x Earnings vs Peers?

Phibro trades near 10x forward earnings vs higher peer multiples as strong Q3 beat, margin gains and 2026 guidance support a modest upside case.

Zacks Investment Research • Jun 11, 2026

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Jun 10, 2026

PAHC vs. SYK: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research • Jun 3, 2026

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Jun 1, 2026

Implied Volatility Surging for Phibro Stock Options

Investors need to pay close attention to PAHC stock based on the movements in the options market lately.

Zacks Investment Research • May 29, 2026